ProText Mobility Inc (TXTM)

[Dr_Q]

DD - CEO UPDATE ON MMJ LICENSING AND CLINICAL TRIALS + MORE

$TXTM's CEO shares with #investors and #traders the progress on #MMJ license Part 1 & 2

youtu.be/YbpvGdM1c0o

In $TXTM - cannabis monopoly South Africa https://t.co/lXPz4LVgMD

— M I C A L O (@MicaloCrypto) May 15, 2017

"Protext Mobility Inc (OTCMKTS:TXTM) Looks To Be A Discount Entry Opportunity"
https://www.insiderfinancial.com/protext-mobility-inc-otcmktstxtm-looks-to-be-a-discount-entry-opportunity/122553/

"$TXTM name change filed with the State of Delaware. New name, Protext Pharma, to better reflect mission and business direction"

$TXTM name change filed with the State of Delaware. New name, Protext Pharma, to better reflect mission and business direction#MMJ #Stocks

— Protext Pharma, Inc ($TXTM) (@protxtm) May 12, 2017

$TXTM making great progress on attaining #medicalcannabis license w/site inspection scheduled for next week by #SA Ministry of Health.

$TXTM making great progress on attaining #medicalcannabis license w/site inspection scheduled for next week by #SA Ministry of Health.

— Protext Pharma, Inc ($TXTM) (@protxtm) May 11, 2017

RECENT PR - "Protext Mobility Signs Agreement With Leading Research Center, CIDP, to Conduct Diabetes Human Clinical Trial"
http://www.marketwired.com/press-release/protext-mobility-signs-agreement-with-leading-research-center-cidp-conduct-diabetes-pinksheets-txtm-2214073.htm




#Shareholders #investors, If you have any questions or would like a call w/ management, you can email your contact info to [e-mail]